ALKBH1 and cancer: While the development of ALKBH1 inhibitors has shown promising results for cancer treatment, several critical issues remain to be addressed for their clinical application, such as determining the minimum effective drug concentration, conducting safety and toxicity evaluations, and assessing efficacy in organoids.